In-Licensing Considerations for Life Sciences Startups
Event summary
11:00 am – 12:00 pm PT
1:00 – 2:00 pm CT
2:00 – 3:00 pm ET
This panel discussion will explore key considerations for companies that are in-licensing biotech or pharmaceutical technologies. Panelists will discuss the top factors that drive value in a licensing deal, including how to structure IP arrangements to advance your goals.
Topics include:
- Exploring different paths to licensing
- How to structure the licensing agreement to enhance value
- Patent due diligence and contemplating co-ownership of patents
Speakers
- Nena Golubovic – Managing Director, IP Group
- Lila Hope – Partner, Cooley
- Amy Baker Mandragouras – Partner, Cooley
- Michael Salgaller – Technology Transfer Center, National Institutes of Health
- Shawn Yu – Associate, Cooley (Moderator)
For more information, please email Seema Desai.
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.